Navigation Links
Pharmaceutical Strategic Initiatives Adds Anne Sexton, MD, MS to Management Team
Date:3/31/2008

DURHAM, N.C., March 31 /PRNewswire/ -- Pharmaceutical Strategic Initiatives (PSI), a provider of marketing consultation and content development services to the pharmaceutical industry, has added Anne L. Sexton MD, MS to its management team as Vice President of Medical Activities.

Dr. Sexton brings 15 years of clinical and pharmaceutical experience to PSI. Dr. Sexton's broad experience includes medical affairs and medical monitoring, drug development strategy, regulatory affairs activities including FDA submissions, drug safety/pharmacovigilance and medical writing.

According to PSI President Charles Carter, PhD, "Anne brings the clinical and industry experience our customers need to develop and implement their integrated medical affairs strategies and support regulatory initiatives."

Prior to joining PSI, Dr. Sexton headed an independent consulting company serving the pharmaceutical and biotech industries.

About Pharmaceutical Strategic Initiatives

PSI was founded in 1988 by Charles Carter, PharmD, MBA and is part of Interactive Holdings. PSI provides strategic marketing consultation and content development services to the pharmaceutical industry. For more information about PSI, contact Mary Messina at 919.314.1380 or visit http://www.psillc.com.


'/>"/>
SOURCE Pharmaceutical Strategic Initiatives
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
2. Caraco Pharmaceutical Laboratories Ltd. To Market Generic Ethyol(R)
3. China Shenghuo Pharmaceutical Holdings, Inc. Schedules Conference Call to Discuss FY 2007 Results
4. Barr Pharmaceuticals, Inc. Executive Bios
5. Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement
6. Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A Clean Slate Approach to the Practice of Pharmaceutical Care
7. Honeywell Expands Aclar(R) Production for Pharmaceutical Industry
8. Surveys Find Key Changes in the Role of the Pharmaceutical CFO
9. KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
10. AUDIO from Medialink and Solvay Pharmaceuticals: Men with Type 2 Diabetes at Increased Risk for Low Testosterone Should Talk to Their Doctors
11. MAP Pharmaceuticals Appoints H. Ward Wolff to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... 04, 2015 , ... An article published July 27th by the ... method for encouraging people to lose weight. Specifically the study compared control patients with ... success, adding a financial incentive to the overall incentive of increased health. According to ...
(Date:8/4/2015)... ... August 04, 2015 , ... It’s hard to ... & Day Spa in Santa Barbara, CA is offering the solution by offering ... permanently eliminates sweat and odor glands in the underarms. This simple and permanent ...
(Date:8/4/2015)... ... 04, 2015 , ... Seedstock’s 4th Annual Sustainable Agriculture Conference, ... 2015, at UC San Diego, will explore innovations that farmers and entrepreneurs are ... resources efficiently against the dueling backdrop of a lingering Western drought and burgeoning ...
(Date:8/4/2015)... ... August 04, 2015 , ... Members receiving care from a ... – at a cost that is nine percent lower -- than those members at ... of New Jersey’s patient-centered programs. , “The promise of patient-centered, or value-based, care ...
(Date:8/4/2015)... ... August 04, 2015 , ... Increasingly, patients are ... calling a physician. In an effort to share more and better information with ... Pennsylvania to publicly share patient satisfaction ratings and comments about its doctors and ...
Breaking Medicine News(10 mins):Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3Health News:UPMC 1st in Pa. to Share Provider Ratings 2Health News:UPMC 1st in Pa. to Share Provider Ratings 3
... Hispanic youth report better dental health habits than their non-Hispanic ... researchers at Columbia University Mailman School of Public Health. ... the Journal of Health Care for the Poor and Underserved, ... community in America. , The study, a snapshot of more ...
... increase cancer growth, cause stroke and heart attacks, revised ... The U.S. Food and Drug Administration on Thursday approved ... which are drugs used to treat certain types of ... and Procrit, and detail their dangers to patients with ...
... Health, Inc.,(Nasdaq: VTIV ) today announced that ... at the 2007 Credit Suisse Healthcare Conference,taking place ... conference will,feature companies spanning all sectors of healthcare, ... presentation will take place on Tuesday, November 13 ...
... Nov. 8 Law Offices of Howard G. Smith,announces ... a lead plaintiff in,the securities class action lawsuit filed ... Micrus Endovascular Corporation ("Micrus" or,the "Company")(Nasdaq: MEND ) ... "Class Period"). The shareholder lawsuit is pending in,the United ...
... Monogram,Biosciences, Inc. (Nasdaq: MGRM ) announced today ... present a corporate overview at the,Lazard Fourth Annual Healthcare ... Time) at the New York Palace Hotel. To ... log on to http://www.monogrambio.com and go to ...
... injury, study finds , THURSDAY, Nov. 8 (HealthDay News) ... may cut their risk for fracture, Canadian researchers report. ... an increased risk of additional fractures, other health problems, ... osteoporosis patients are hip, spine, and wrist fractures. ...
Cached Medicine News:Health News:Study of minority New York City youth finds unequal burden of poor dental health 2Health News:FDA Issues New Warnings for Anemia Drugs 2Health News:FDA Issues New Warnings for Anemia Drugs 3Health News:inVentiv Health to Present at the 2007 Credit Suisse Healthcare Conference 2Health News:Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference 2Health News:Sticking With Meds Lowers Elderly Fracture Risk 2
(Date:8/3/2015)... , Aug. 4, 2015   The Intellectual ... the world,s leading provider of intelligent information for ... 2015 CMR Pharmaceutical R&D Factbook , the ... Despite concerns around declines in R&D, the analysis ... $1 trillion milestone and forecasts sales to reach ...
(Date:8/3/2015)... (NASDAQ: LMNX ) today announced financial results for ... operating highlights for the quarter include the following: ... percent to $58.9 million, over the second quarter of ... by 22 percent to $24.2 million over results from ... 2015 royalty revenue by 17 percent to $11.1 million ...
(Date:8/3/2015)... -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ), a ... of innovative therapies for the treatment of acute pain, ... for the three and six months ended June 30, ... July 23, 2015, the Committee for Medicinal Products for ... for the management of acute moderate-to-severe post-operative pain in ...
Breaking Medicine Technology:Pharma Sales to Grow Beyond $1 Trillion 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 3Luminex Corporation Reports Record 2nd Quarter 2015 Results 4Luminex Corporation Reports Record 2nd Quarter 2015 Results 5Luminex Corporation Reports Record 2nd Quarter 2015 Results 6Luminex Corporation Reports Record 2nd Quarter 2015 Results 7Luminex Corporation Reports Record 2nd Quarter 2015 Results 8Luminex Corporation Reports Record 2nd Quarter 2015 Results 9Luminex Corporation Reports Record 2nd Quarter 2015 Results 10Luminex Corporation Reports Record 2nd Quarter 2015 Results 11Luminex Corporation Reports Record 2nd Quarter 2015 Results 12Luminex Corporation Reports Record 2nd Quarter 2015 Results 13Luminex Corporation Reports Record 2nd Quarter 2015 Results 14Luminex Corporation Reports Record 2nd Quarter 2015 Results 15Luminex Corporation Reports Record 2nd Quarter 2015 Results 16AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 2AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 3AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 4AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 5AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 6AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 7AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 8AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 9AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 10
... and Progressive Form of Inflammatory Spinal Arthritis Receiving Monthly Golimumab ... ... BOSTON, Nov. 7 More than half of patients receiving,monthly ... experienced significant and sustained improvements in the signs and,symptoms of active ...
... of Trial Volunteers Must Remain Paramount Concern, SEATTLE, ... the following statement today from Executive,Director Mitchell Warren in ... AIDS vaccine study by Merck & Co., the US ... HIV Vaccine Trials Network,(HVTN) at a public forum at ...
Cached Medicine Technology:New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 2New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 3New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 4New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 5New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 6New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings 7AIDS Vaccine Advocacy Coalition Calls for AIDS Vaccine Field to Work Together to Analyze STEP Study Data and Determine Best Course to Move Forward 2AIDS Vaccine Advocacy Coalition Calls for AIDS Vaccine Field to Work Together to Analyze STEP Study Data and Determine Best Course to Move Forward 3
... copolymer is an absorbable co-polymer synthesized ... and 18% glycolic acid. Unlike the ... 100% poly-L-lactic acid (PLLA) or 100% ... substantially amorphous (without crystallinity), meaning that ...
... POLYSORB™ Soft Tissue Anchor 3 mm is a ... to bone using sutures. The resorbable repair device ... bone, and is used to attach soft tissue. ... copolymer, derived from glycolide and lactide colored with ...
Umbrella Cancellous Harpoon...
... anchor is generally utilized when a surgeon would ... bone. Unlike other anchors that require the surgeon ... have that limitation. The only instrument required to ... The 4.4mm Stainless Steel Anchor is packaged sterile ...
Medicine Products: